$8.60
▲ +$0.02
(+0.23%)
Vol 32K
5
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$129.6M
ROE
-4.6%
Margin
-2.3%
D/E
0.00
Beta
1.35
52W
$8–$13
Wall Street Consensus
10 analysts · Apr 20262
Strong Buy
4
Buy
4
Hold
0
Sell
0
Strong Sell
60.0%
Buy Rating
Price Chart
Earnings
Beat rate: 60.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $0.04 | $0.07 | +$0.03 |
| Sep 2025 | $0.00 | $0.02 | +$0.02 |
| Jun 2025 | $-0.02 | $-0.06 | $-0.04 |
| Mar 2025 | $0.00 | $-0.03 | $-0.03 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Revenue | — | -$38.3M | $13.1M | $13.3M | $13.4M | $15.2M |
| Net Income | — | -$2.7M | $968K | $93K | $855K | $991K |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -24.5% | -24.5% | -24.5% | -24.5% | -4.6% | -4.6% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | 0.7% | -6.1% | -6.1% | -6.1% | -2.3% | -2.3% |
| Gross Margin | 79.1% | 82.1% | 82.1% | 82.1% | 78.4% | 78.4% |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 1.80 | 1.80 | 1.80 | 1.80 | 1.83 | 1.83 |
Key Ratios
ROA (TTM)
-1.3%
P/S (TTM)
1.65
P/B
8.9
EPS (TTM)
$-0.07
CF/Share
$0.65
Rev Growth 3Y
-13.4%
52W High
$13.47
52W Low
$7.50
$7.50
52-Week Range
$13.47
Financial Health
Free Cash Flow
$2.5M
Net Debt
-$21.6M
Cash
$23.6M
Total Debt
$2.0M
As of Dec 31, 2025
How does JYNT compare to Health Care peers?
Peer group: Micro-cap Health Care (All) · 241 companies
JYNT valuation vs Health Care peers
P/E ratio
—
▼
0%
below
peers
(30.7)
vs Peers
vs Industry
Undervalued
P/S ratio
1.7
▼
36%
below
peers
(2.6)
vs Peers
vs Industry
Pricier
P/B ratio
8.9
▲
220%
above
peers
(2.8)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.7%)
vs Peers
vs Industry
Low yield
JYNT profitability vs Health Care peers
ROE
-4.6%
▲
88%
above
peers
(-38.5%)
vs Peers
vs Industry
Below avg
Net margin
-2.3%
▲
91%
above
peers
(-24.7%)
vs Peers
vs Industry
Below avg
Gross margin
78.4%
▲
48%
above
peers
(52.9%)
vs Peers
vs Industry
Top tier
ROA
-1.3%
▲
94%
above
peers
(-21.2%)
vs Peers
vs Industry
Below avg
JYNT financial health vs Health Care peers
D/E ratio
0.0
▼
100%
below
peers
(19.3)
vs Peers
vs Industry
Low debt
Current ratio
1.8
▼
15%
below
peers
(2.2)
vs Peers
vs Industry
In line
Beta
1.4
▲
29%
above
peers
(1.1)
vs Peers
vs Industry
More volatile
JYNT fundamentals radar
JYNT
Peer median
Industry
JYNT profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
JYNT vs peers: key metrics
Insider Activity
NeutralBuys
0
Sells
0
RAZDAN SANJIV KUMAR
Chief Executive Officer · Mar 09
73484 shs
BOWMAN SCOTT JUSTIN
Chief Financial Officer · Mar 09
28301 shs
JOBSON CHARLES E
Beneficial Owner of more than… · Feb 12
15397 shs
JOBSON CHARLES E
Beneficial Owner of more than… · Feb 11
448 shs
JOBSON CHARLES E
Beneficial Owner of more than… · Jan 26
17478 shs
JOBSON CHARLES E
Beneficial Owner of more than… · Jan 06
5240 shs
Last 90 days
Top Holders
Top 5: 52.35%Bandera Partners LLC
27.90%
$33.2M
Vanguard Group Inc
7.09%
$8.4M
Blackrock Inc.
6.84%
$8.2M
Skylands Capital, LLC
6.31%
$7.5M
JCP Investment Management, …
4.21%
$5.0M
As of Dec 31, 2025
Latest News
No related news yet